Early treatment-related morbidity and mortality of children with non-Hodgkin's lymphoma treated at Tikur Anbesa Specialized Hospital with modified ALCL protocol: prospective cohort study.

ABSTRACT:

Background

Childhood non-Hodgkin lymphoma is a varied collection of malignant neoplasms that includes all lymphomas that are not categorized as Hodgkin lymphoma. It is the third most prevalent malignancy after leukemia and brain tumors. Over the last twenty years, significant improvements in chemotherapy combination, intensification, and supportive care have led to significant survival in high-income countries. However, in low- and middle-income countries, underlying malnutrition, delayed and advanced presentation, inadequate supportive care, and infection lead to poor overall outcomes and treatment-related early or late mortality; this study aimed to Assess, early induction phase treatment-related mortality and associated factors of children with non-Hodgkin's Lymphoma treated at

SUBMITTER: Nigusie M 

PROVIDER: S-EPMC12482131 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature